Impax Asset Management Group PLC Cytokinetics Inc Transaction History
Impax Asset Management Group PLC
- $23 Billion
- Q3 2024
A detailed history of Impax Asset Management Group PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Impax Asset Management Group PLC holds 125,000 shares of CYTK stock, worth $5.73 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
125,000
Previous 125,000
-0.0%
Holding current value
$5.73 Million
Previous $6.6 Million
-0.0%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
407Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$672 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$539 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$444 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$356 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$296 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.31B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...